Subscribe
doj
traveler1116 / iStockphoto.com
20 July 2020AmericasMuireann Bolger

Ukrainians plead guilty to trafficking counterfeit drugs into the US

Two citizens of  Ukraine have admitted to smuggling and distributing counterfeit cancer and hepatitis drugs into the US at the  Southern District Court of Texas on July 17, according to  the  US Department of Justice.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
3M secures another settlement in price-gouging campaign
22 July 2020   3M has obtained a permanent injunction from an Ohio judge, as part of its settlement in a lawsuit filed against a company it accused of reselling N95 masks at “grossly inflated” prices amid the COVID-19 pandemic.
Americas
DOJ chief wades into dental antitrust case in rare intervention
9 July 2020   The antitrust chief of the US Justice Department (DOJ) made a rare appearance in court when he requested that the US Court of Appeals for the Eleventh Circuit reject a defence used by a medical and dental board against an antitrust lawsuit.
Americas
DoJ sues company for selling unapproved drugs and supplements
21 February 2017   The US Department of Justice has asked for an injunction to stop a Louisiana-based drug and dietary supplement manufacturer from distributing misbranded and unapproved new drugs and dietary supplements.


Editor's picks

Killing the golden goose of US drug innovation (Part II): Drug pricing myths
Americas
Killing the golden goose of US drug innovation (Part II): Drug pricing myths
12 September 2025

Editor's picks

Americas
Killing the golden goose of US drug innovation (Part II): Drug pricing myths
12 September 2025
Americas
Smart ringleader: Could Ōura’s market dominance be under threat?
5 September 2025
Americas
Why Masimo’s ‘rare’ move pushes Apple case into uncharted territory
3 September 2025
Europe
Sandoz blocked by UK court from seeking Xarelto profits
2 September 2025
Europe
UPC sees rising small molecule litigation with Pfizer in the hot seat
29 August 2025
Europe
Astellas win strengthens blockbuster drug's European position
20 August 2025

More features

The Quintara decision: Defining trade secrets in federal cases
To disclose or not: Pharma patents face new AI reality
Trade secrets go global: How brand owners face a high-stakes battlefront
Killing the golden goose of US drug innovation (Part II): Drug pricing myths
Former pharma GC brings in-house perspective to McGuireWoods
Sandoz eyes US biosimilar launch as Regeneron settles
Killing the golden goose of US drug innovation (Part I): Follow the money
Buchalter brings in new partner to head up medtech